Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-09Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathy Using a Preparative Regimen to Achieve Stable Mixed Chimerism
-
CLINICAL_TRIALS study record update · 2017-05-03A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-04-26Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Doppler Ultrasound Using Reduced-Intensity Conditioning and T-Cell Depleted HSC From Partially Matched Family Donors
-
CLINICAL_TRIALS study record update · 2017-04-19National Project for Healthcare Assessment of SCD Children Diagnosed by Newborn Screening in France
-
CLINICAL_TRIALS study record update · 2017-04-13Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-12A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of GBT440 on the Pharmacokinetics of Probe Substrates for CYP1A2, CYP2C9, CYP2C19, and CYP3A4 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2017-04-12A Phase 1, Single-Dose, Open-Label, Randomized, Two-Period Crossover Study to Evaluate the Relative Bioavailability of GBT440 300 mg Administered as Capsule Formulations in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2017-03-28Molecular Phenotyping of Asthma in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-03-24PCA for Pain Control in Adults With Sickle Cell Disease in the Emergency Department (ED) Decreases Admission Rates Over Standard Bolus Therapy
-
CLINICAL_TRIALS study record update · 2017-03-24A Phase 2, Exploratory, Placebo-Controlled, Multicenter, Double-Blind Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Two Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-03-01An Extended Phase 2 Study of Decitabine in Subjects With High Risk Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-02-17Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
-
CLINICAL_TRIALS study record update · 2017-02-08A Safety and Efficacy Evaluation of Sodium Nitrite Injection for the Treatment of Vaso-Occlusive Crisis Associated With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-02-01WEB MAP Intervention for Youth With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-01-25Feasibility of Implementing Mental Health Treatment in Routine Adult Sickle Cell Disease Care Using Online Cognitive Behavioral Therapy and a Mobile Technology-Based Intervention
-
CLINICAL_TRIALS study record update · 2017-01-19Androgen Regulation of Priapism in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2017-01-04A Pilot Study of Fecal Microbiome and Neutrophil Cellular Adhesion Molecules in Patients With Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study record update · 2016-12-23Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
-
CLINICAL_TRIALS study record update · 2016-12-19Phase 2 Study of Simvastatin Treatment Effects on Vaso-occlusive Pain in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2016-10-28Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2016-10-28Evaluation of Repeat Administration of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC-E): An Open-Label Safety Extension Trial Assessing Repeat Administration of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2016-10-27Integrating a Parenting Intervention With Routine Care to Improve Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2016-10-05Harmful Effects of Transfusion of Older Stored Red Cells: Iron and Inflammation
-
CLINICAL_TRIALS study record update · 2016-09-21High-Tc Susceptometer to Monitor Transfusional Iron Overload (NSR Device)
-
CLINICAL_TRIALS study record update · 2016-09-19Investigation in Sickle Cell Disease of a New Reagent Assay Examining Natural Parvovirus B19 Infection